The significant reduction in tumor growth and improved survival in patients with cancer treated with monoclonal neutralizing antibodies against PD-L1 or PD-1 illustrates the important role of the immune checkpoint molecules in cancer invasiveness [55]. The gene discussed is CD274; the disease is neoplasm.